by susan.forootan | Apr 18, 2024
The Thy-1-α-synuclein mouse model of Parkinson’s disease is a transgenic mouse model that over-expresses wild-type human alpha-synuclein under the Thy1 promoter in neurons. The model exhibits dopaminergic neuronal loss, alpha-synuclein aggregates, neuroinflammation,...
by susan.forootan | Apr 12, 2024
Spinal cord injury (SCI) is produced most often by a traumatic injury that bruises and partially tears the spinal cord tissue. The lesion causes temporary or permanent changes in sensation, movement, strength, and autonomic body functions below the level of injury....
by susan.forootan | Mar 11, 2024
The below data was made possible by CMTA, the Charcot-Marie-Tooth Association. Charcot-Marie-Tooth (CMT) disorders are a family of related disorders that produce progressive distal neuropathies, presenting significant challenges for patients and society. CMT2E is...
by susan.forootan | Feb 26, 2024
The below data was made possible by CMTA, the Charcot-Marie-Tooth Association. Charcot-Marie-Tooth (CMT) disorders are a family of related disorders that produce progressive distal neuropathies, presenting significant challenges for patients and society. CMT2A is...
by susan.forootan | Feb 15, 2024
Angelman Syndrome (AS) is a rare genetic neurodevelopmental disorder characterized, in part, by developmental delays, movement impairments, and difficulties with communication and language, the effects of which impact children and adults living with AS along with...
